Income StatementBalance SheetCash FlowSegments
ResMed logo

ResMed Balance Sheet Statement

Assets, liabilities, and shareholders' equity

ResMed holds $8.8B in total assets. Shareholders' equity is $6.5B against $1.4B in total debt. Cash and equivalents total $1.7B. The current ratio is 3.01 and debt-to-equity is 0.210. Based on the Q1 2026 filing.

Total Assets$8.8BTotal Stockholders Equity$6.5BLong Term Debt$664.1MCash And Equivalents$1.7BTotal Current Assets$4.1BTotal Current Liabilities$1.4B
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$29.6B
P/E Ratio19.49
ROE25.25%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$220.3M$222.6M$278.2M$266.8M$250.4M$273.3M
Accrued Contingent Liabilities$700.0K$700.0K$700.0K$700.0K$800.0K$800.0K
Accrued expenses$352.5M$386.3M$402.3M$395.8M$391.5M$446.1M
Accrued Progress Collections and Price Adjustments$146.5M$151.1M$156.8M$159.4M$159.8M$163.1M
Other Commercial Liabilities$352.5M$386.3M$402.3M$395.8M$391.5M$446.1M
Contract liabilities$146.5M$151.1M$156.8M$159.4M$159.8M$163.1M
Accrued Income Taxes, Current$84.9M$132.5M$132.3M$135.2M$140.5M$163.3M
Accrued Liabilities, Current$352.5M$386.3M$402.3M$395.8M$391.5M$446.1M
Current portion of long-term debt$9.9M$9.9M$9.9M$259.9M$259.9M$259.9M
Deferred revenue$156.5M$160.4M$166.0M$167.8M$176.1M$179.3M
Derivative Liabilities - Fair Value$18.2M$47.8M$132.8M$136.7M$128.0M$145.4M
Income taxes payable$84.9M$132.5M$132.3M$135.2M$140.5M$163.3M
Operating lease liabilities, current$27.8M$28.7M$30.5M$30.0M$29.8M$29.2M
Restructuring Reserve———$11.7M$6.0M$1.6M
Short-term borrowings$9.9M$9.9M$9.9M$259.9M$259.9M$259.9M
Total current liabilities$852.0M$940.5M$1.0B$1.3B$1.2B$1.4B

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$859.9M$907.8M$939.5M$907.3M$985.6M$998.8M
Allowance for Doubtful Accounts$20.7M$19.8M$22.4M$24.6M$29.2M$29.5M
Allowance for Doubtful Accounts Receivable (Current)$20.7M$19.8M$22.4M$24.6M$29.2M$29.5M
Cash and cash equivalents$521.9M$932.7M$1.2B$1.4B$1.4B$1.7B
Contract assets——$51.2M$51.1M$61.4M$47.1M
Finished goods$514.7M$516.4M$557.9M$580.5M$546.3M$559.0M
Other current assets$196.6M$216.2M$164.5M$160.7M$179.9M$190.9M
Deferred Finance Costs, Current$94.0K$94.0K$100.0K$101.0K$94.0K$72.0K
Derivative assets$12.6M$9.9M$6.8M$8.1M$7.5M$7.4M
Income taxes receivable$171.6M$191.2M$165.0M$151.3M$229.5M$229.7M
Finished goods$514.7M$516.4M$557.9M$580.5M$546.3M$559.0M
Raw materials$364.8M$343.0M$367.3M$363.4M$374.7M$350.9M
Work in process$2.6M$3.3M$2.6M$2.0M$968.0K$2.0M
Inventories$882.1M$862.6M$927.7M$945.8M$922.0M$911.9M
Prepaid expenses and other current assets$572.2M$505.2M$429.0M$388.8M$494.1M$492.8M
Total current assets$2.8B$3.2B$3.5B$3.6B$3.8B$4.1B
Trading Securities in Marketable Securities$66.5M$65.4M$63.6M$64.5M$64.8M$78.5M

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Additional paid-in capital$2.0B$2.0B$2.0B$2.1B$2.1B$2.1B
Accumulated other comprehensive income (loss)-$298.9M-$250.9M-$74.7M-$60.7M-$29.9M-$24.9M
Common stock$760.0K$761.0K$761.0K$762.0K$763.0K$763.0K
Common Stock Par Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Common Stock Shares Issued190M190.1M190.3M190.4M190.8M190.9M
Convertible Preferred Stock Authorized Shares2M2M2M2M2M2M
Convertible Preferred Stock Issued Shares000000
Additional paid-in capital$2.0B$2.0B$2.0B$2.1B$2.1B$2.1B
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding$0.0$0.0$0.0$0.0$0.0$0.0
Preferred stock$0.0$0.0$0.0$0.0$0.0$0.0
Preferred Stock Par Value Per Share$0.01$0.01$0.01$0.01$0.01$0.01
Retained earnings$5.5B$5.8B$6.1B$6.3B$6.6B$7.0B
Total liabilities and stockholders' equity$7.1B$7.6B$8.2B$8.3B$8.5B$8.8B
Total stockholders' equity$5.3B$5.5B$6.0B$6.1B$6.3B$6.5B
Treasury stock$1.9B$2.0B$2.1B$2.2B$2.4B$2.6B

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Contract Liabilities, Non-Current$146.5M$151.1M$156.8M$159.4M$159.8M$163.1M
Long-term debt$672.8M$673.0M$668.3M$668.6M$663.8M$664.1M
Deferred revenue, net of current portion$146.5M$151.1M$156.8M$159.4M$159.8M$163.1M
Operating lease liabilities, non-current$139.2M$138.0M$153.0M$147.8M$154.1M$149.8M
Other non-current liabilities$10.8M$49.0M$141.5M$138.2M$138.5M$146.1M
Total Carrying Value of Debt$665.0M$665.0M$660.0M$410.0M$405.0M$405.0M
Total liabilities$1.9B$2.0B$2.2B$2.2B$2.2B$2.3B
Total noncurrent liabilities$1.0B$1.1B$1.2B$931.6M$934.4M$941.2M
Unrecognized Tax Benefits$77.0M$79.0M$77.7M$77.6M$78.0M$77.9M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Cumulative Cost Basis$1.2B$1.2B$1.3B$1.3B$1.3B$1.3B
Gross Assets/Liabilities$18.2M$47.8M$132.8M$136.7M$128.0M$145.4M
Allowance for doubtful accounts$20.7M$19.8M$22.4M$24.6M$29.2M$29.5M
Common stock, par value (in dollars per share)$0.0$0.0$0.0$0.0$0.0$0.0
Common stock, shares authorized (in shares)$350.0M$350.0M$350.0M$350.0M$350.0M$350.0M
Common stock, shares issued (in shares)$190.0M$190.1M$190.3M$190.4M$190.8M$190.9M
Common Stock, Shares, Outstanding$146.9M$146.6M$146.4M$145.9M$145.7M$145.0M
Long-term debt, gross$665.0M$665.0M$660.0M$410.0M$405.0M$405.0M
Deferred Finance Costs Noncurrent Net$2.1M$1.9M$1.6M$1.3M$1.1M$832.0K
Deferred Income Taxes and Other Tax Liabilities, Noncurrent$77.0M$79.0M$77.7M$77.6M$78.0M$77.9M
Derivative Liability$18.2M$47.8M$132.8M$136.7M$128.0M$145.4M
Equity Investments$147.0M$146.4M$152.9M$150.1M$153.5M$163.7M
Equity Investments, Total by Measurement Category$147.0M$146.4M$152.9M$150.1M$153.5M$163.7M
Equity method investments (Note 11)$65.7M$68.9M$76.2M$77.6M$79.4M$79.8M
Trading securities, cost$66.5M$65.4M$63.6M$64.5M$64.8M$78.5M
Loss Contingency Accrual$700.0K$700.0K$700.0K$700.0K$800.0K$800.0K
Loss Contingency Estimate Of Possible Loss$28.5M$35.5M$34.1M$25.5M$27.3M$33.8M
Fair value$14.8M$12.1M$13.1M$8.0M$9.3M$5.5M
Number of patents6.00———5.00—
Preferred Stock, Par or Stated Value Per Share$0.0$0.0$0.0$0.0$0.0$0.0
Preferred Stock, Shares Authorized$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M
Preferred Stock, Shares Issued$0.0$0.0$0.0$0.0$0.0$0.0
Prepaid inventories$104.2M$66.2M$48.2M$25.7M$23.2M$25.1M
Restructuring Reserve———$11.7M$6.0M$1.6M
Short-term debt$10.0M$10.0M$10.0M$260.0M$260.0M$260.0M
Treasury stock, shares (in shares)$43.2M$43.5M$43.9M$44.4M$45.2M$45.8M

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Deferred Tax Assets and Other Non-Current Assets$209.4M$216.8M$253.1M$275.9M$285.9M$312.6M
Equity method investments$66.5M$65.4M$63.6M$64.5M$64.8M$78.5M
Equity Securities Without Readily Determinable Fair Value - Cumulative Downward Adjustments$66.5M$65.4M$63.6M$64.5M$64.8M$78.5M
Goodwill$2.8B$2.8B$3.0B$3.0B$3.0B$3.0B
Intangible assets, net$438.0M$430.1M$464.9M$447.1M$430.2M$425.2M
Investments - Amortized Cost Basis$66.5M$65.4M$63.6M$64.5M$64.8M$78.5M
Intangible assets — net$438.0M$430.1M$464.9M$447.1M$430.2M$425.2M
Operating lease right-of-use assets$151.0M$152.6M$167.5M$162.0M$165.9M$161.6M
Other non-current assets$181.2M$174.6M$185.8M$189.8M$193.9M$210.7M
Property, plant and equipment at cost$1.2B$1.2B$1.3B$1.3B$1.3B$1.3B
Operating lease right-of-use assets$151.0M$152.6M$167.5M$162.0M$165.9M$161.6M
Operating Lease Right-of-Use Assets in Other Assets$151.0M$152.6M$167.5M$162.0M$165.9M$161.6M
Other non-current assets$209.4M$216.8M$253.1M$275.9M$285.9M$312.6M
Accumulated depreciation$694.2M$697.9M$705.3M$723.0M$748.0M$779.3M
Property and equipment, net$520.2M$535.3M$550.8M$563.6M$564.3M$567.0M
Software and Technology Licenses, Net$181.2M$174.6M$185.8M$189.8M$193.9M$210.7M
Total assets$7.1B$7.6B$8.2B$8.3B$8.5B$8.8B
Total noncurrent assets$4.3B$4.4B$4.7B$4.7B$4.7B$4.7B